The Daily Bolus: The Triple Agonist Showdown & Surprising GLP-1 Wins in Type 1 Diabetes
Welcome to today's edition of The Daily Bolus! The incretin landscape is rapidly evolving into the era of the "triple agonist," with Eli Lilly and Novo Nordisk going head-to-head to push weight loss and A1C reduction to new extremes. Meanwhile, groundbreaking real-wor
https://www.diabettech.com/the-daily-bolus-the-triple-agonist-showdown-surprising-glp-1-wins-in-type-1-diabetes/
#DailyBolus #Incretins

The Daily Bolus: Early Warnings, Genetic Cloaks, and the Seven-Year Shield
Whilst the title of this edition sounds like something out of  science fiction, in it we see a masterclass in "biological intelligence." As of February 5, 2026, the signal cutting through the noise has shifted from hardware on the skin to the deep cellular architecture of the body. From "immune niches"
https://www.diabettech.com/the-daily-bolus-early-warnings-genetic-cloaks-and-the-seven-year-shield/
#DailyBolus

The Daily Bolus: Mechanism over metrics, biology over dashboards
The developments highlighted in the bolus today reinforce a theme Diabettech has been circling for years: the most meaningful progress in diabetes does not come from squeezing ever more signal out of glucose curves, but from understanding the biology that sits underneath them.
Not all of these are from the past 24 hours,
https://www.diabettech.com/the-daily-bolus-mechanism-over-metrics-biology-over-dashboards/
#DailyBolus

The Daily Bolus: Et tu, B Cells?
Recent news has been defined by a pivot toward "biological intelligence." As of January 21, 2026, the signal cutting through the noise isn't just about managing the disease after it arrives, but about uncovering the "hidden" sabotage within our immune systems and identifying at-risk children before the first symptom ever appears.
1. The "Sinister" Saboteurs: B Cells vs. The Peacekeepe
https://www.diabettech.com/the-daily-bolus-et-tu-b-cells/
#DailyBolus

The Daily Bolus: What happened over the weekend?
The Daily Bolus
The weekend news has produced a rare mix of genuinely interesting diabetes science alongside the usual commercial background noise. Notably, some of the most consequential developments did not originate from device manufacturers or glucose-lowering drug pipelines, but from immune biology, metabolomics, and long-term disease-modification
https://www.diabettech.com/the-daily-bolus-what-happened-over-the-weekend/
#DailyBolus

The Daily Bolus: Enhancing Biological Precision?
The last 24 hours in the diabetes space have been characterized by a quiet but firm shift from "what if" to "how soon." As of January 15, 2026, the signal cutting through the noise isn't a singular "cure" headline, but a series of technical milestones in automated delivery, genomic risk-mapping, and the ongoing, messy evolution of implanted cell therapi
https://www.diabettech.com/the-daily-bolus-enhancing-biological-precision/
#DailyBolus